These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6175804)

  • 1. Effect of alinidine on experimental cardiac arrhythmias.
    Harron DW; Allen JD; Wilson R; Shanks RG
    J Cardiovasc Pharmacol; 1982; 4(2):221-5. PubMed ID: 6175804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lignocaine and propranolol on experimental cardiac arrhythmias.
    Allen JD; Shanks RG; Zaidi SA
    Br J Pharmacol; 1971 May; 42(1):1-12. PubMed ID: 4103275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electropharmacology of the bradycardic agents alinidine and zatebradine (UL-FS 49) in a conscious canine ventricular arrhythmia model of permanent coronary artery occlusion.
    Aidonidis I; Brachmann J; Rizos I; Zacharoulis A; Stavridis I; Toutouzas P; Kübler W
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):555-63. PubMed ID: 8547205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the myocardial-selective alpha 1-adrenoceptor antagonist UK-52046 and atenolol, alone and in combination, on experimental cardiac arrhythmias in dogs.
    Uprichard AG; Harron DW; Wilson R; Shanks RG
    Br J Pharmacol; 1988 Dec; 95(4):1241-54. PubMed ID: 2905912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tiprenolol, practolol and propranolol on experimental ventricular tachyarrhythmias.
    Allen JD; Shanks RG
    Br J Pharmacol; 1974 Jun; 51(2):179-85. PubMed ID: 4155971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmias.
    Allen JD; Ekue JM; Shanks RG; Zaidi SA
    Br J Pharmacol; 1972 Aug; 45(4):561-73. PubMed ID: 5085230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in systemic haemodynamics, regional myocardial function and perfusion induced by alinidine in pigs with and without narrowed coronary arteries.
    Verdouw PD; Duncker DJ; Heere TJ; Saxena PR
    Eur Heart J; 1987 Dec; 8 Suppl L():43-52. PubMed ID: 3451882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative chronotropic and parasympatholytic effects of alinidine on canine sinus node and AV junction.
    Hageman GR; Neely BH; Urthaler F; James TN
    Am J Physiol; 1985 Mar; 248(3 Pt 2):H324-30. PubMed ID: 3976903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic and cardiovascular effects of MP 115.
    Allen JD; Deering AH; Kelly JG; Shanks RG
    J Cardiovasc Pharmacol; 1983; 5(6):937-44. PubMed ID: 6196565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac electrophysiologic effects of alinidine, a specific bradycardic agent, in the conscious dog: plasma concentration-response relations.
    Boucher M; Chassaing C; Chapuy E
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):229-33. PubMed ID: 7752648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivity of alinidine, a bradycardic agent, for SA nodal automaticity versus other cardiac activities in isolated, blood-perfused dog-heart preparations.
    Kawada M; Satoh K; Taira N
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):88-102. PubMed ID: 6517649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic properties of 5-(3-tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a newly synthesized, potent beta-adrenoreceptor antagonist.
    Yabuuchi Y; Hashimoto K; Yamashita S; Uno T; Shintani S; Nakagiri N
    Clin Exp Pharmacol Physiol; 1977; 4(6):545-59. PubMed ID: 22416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glucagon on arrhythmias induced by coronary artery occlusion and ouabain in dogs.
    Singh J; Bala S; Kaur AH; Garg KN
    Indian J Physiol Pharmacol; 1980; 24(4):329-34. PubMed ID: 7216388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on atrio-ventricular conduction of alinidine and falipamil injected into the AV node artery of the anesthetized dog.
    Takeda M; Furukawa Y; Ogiwara Y; Saegusa K; Haniuda M; Akahane K; Chiba S
    Arch Int Pharmacodyn Ther; 1989; 297():39-48. PubMed ID: 2730241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiarrhythmic and cardiovascular properties of 1-dimethyl isopropylamino-3-(2-phenylphenoxy)-propan-2-ol chloride, UM-424.
    Kniffen FJ; Winokur S; Counsell RE; Lucchesi BR
    J Pharmacol Exp Ther; 1976 Feb; 196(2):420-32. PubMed ID: 3643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac electrophysiological effects of falipamil in the conscious dog: comparison with alinidine.
    Boucher M; Chassaing C; Chapuy E
    Eur J Pharmacol; 1996 Jun; 306(1-3):93-8. PubMed ID: 8813620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifibrillatory properties of alinidine after coronary artery occlusion in rats.
    Harron DW; Brezina M; Lillie C; Kobinger W
    Eur J Pharmacol; 1985 Apr; 110(3):301-8. PubMed ID: 4007054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of chronotropic cardiac effects of alinidine and plasma concentration-response relationships in the conscious dog with chronic atrioventricular block.
    Boucher M; Chapuy E; Lefebvre MA; Mignot A; Duchêne-Marullaz P
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):630-7. PubMed ID: 2570365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of bretylium on experimental cardiac dysrhythmias.
    Allen JD; Zaidi SA; Shanks RG; Pantridge JF
    Am J Cardiol; 1972 May; 29(5):641-9. PubMed ID: 5021494
    [No Abstract]   [Full Text] [Related]  

  • 20. Alinidine reduces the incidence of ischemic ventricular fibrillation in a conscious canine model, a protective effect antagonized by overdrive atrial pacing.
    Uprichard AC; Chi LG; Lynch JJ; Driscoll EM; Frye JW; Lucchesi BR
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):475-82. PubMed ID: 2476629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.